Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genkyotex’s liver disease drug GKT831 succeeds in phase 2 trial
Image: Genkyotex’s GKT831 succeeds in phase 2 trial in primary biliary cholangitis. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.
Image: Genkyotex’s GKT831 succeeds in phase 2 trial in primary biliary cholangitis. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.